• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » MLSC, COBTH, UMass Med launch web portal to promote collaboration

MLSC, COBTH, UMass Med launch web portal to promote collaboration

June 17, 2015
CenterWatch Staff

The Massachusetts Life Sciences Center (MLSC) partnered with the Conference of Boston Teaching Hospitals (COBTH) and the University of Massachusetts Memorial Medical Center to the launch the Massachusetts Clinical Innovation Gateway. The new web portal will allow life sciences companies from around the world to seek opportunities to partner with Massachusetts academic medical centers (AMCs) on research and clinical initiatives.

The MLSC and COBTH have developed a form and process to triage partnership requests from interested life sciences companies. Companies seeking to explore partnership opportunities with Massachusetts AMC’s can complete the online form, which will be sent to representatives from each of the AMCs for review and consideration.

Participating AMCs include:

  • Beth Israel Deaconess Medical Center
  • Boston Children's Hospital
  • Boston Medical Center
  • Brigham and Women's Faulkner Hospital
  • Brigham and Women's Hospital
  • Cambridge Health Alliance
  • Carney Hospital
  • Dana-Farber Cancer Institute
  • Floating Hospital for Children at Tufts Medical Center
  • Lahey Hospital and Medical Center
  • Massachusetts Eye and Ear
  • Massachusetts General Hospital
  • St. Elizabeth's Medical Center
  • Tufts Medical Center
  • UMass Memorial Medical Center
  • VA Boston Healthcare

“This new tool will enable medical breakthroughs by offering companies in Massachusetts and throughout the world the opportunity to collaborate on product development and clinical studies with Massachusetts’ world-renowned research hospitals,” said Pamela Norton, MLSC vice president for Industry Relations and Programs. “We are excited about the collaborations that will result, the improvements in patient care that will follow, and the role that this new system will play in attracting even more global companies to the Massachusetts life sciences ecosystem.”

Through the MLSC, Massachusetts is investing $1 billion over 10 years in the growth of the state’s life sciences ecosystem. Through nearly $600 million in public investment, which has leveraged more than $1.7 billion in third-party investment, Massachusetts has emerged as the global leader in life sciences, and as a magnet for companies large and small from all over the world.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing